According to some studies, the p53 signaling pathway can decrease cancers via modulating cell cycle arrest [21], angiogenesis inhibition [22], DNA repair and angiogenesis [23], apoptosis [22], etc. As a result, altering the p53 signaling pathway may be a therapeutic approach for colorectal cancer treatment. This evidence concerns the gene TP53 and cancer.